BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

709 related articles for article (PubMed ID: 10353939)

  • 1. Growth, puberty, and endocrine functions in patients with sporadic or familial neurofibromatosis type 1: a longitudinal study.
    Carmi D; Shohat M; Metzker A; Dickerman Z
    Pediatrics; 1999 Jun; 103(6 Pt 1):1257-62. PubMed ID: 10353939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disorders of Puberty: An Approach to Diagnosis and Management.
    Klein DA; Emerick JE; Sylvester JE; Vogt KS
    Am Fam Physician; 2017 Nov; 96(9):590-599. PubMed ID: 29094880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disorders of childhood growth and development: precocious puberty.
    Chauhan A; Grissom M
    FP Essent; 2013 Jul; 410():25-31. PubMed ID: 23869392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Height prognosis of children with true precocious puberty and growth hormone deficiency: effect of combination therapy with gonadotropin releasing hormone agonist and growth hormone.
    Cara JF; Kreiter ML; Rosenfield RL
    J Pediatr; 1992 May; 120(5):709-15. PubMed ID: 1533661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth, puberty and hypothalamic-pituitary function in children with suprasellar arachnoid cyst.
    Adan L; Bussières L; Dinand V; Zerah M; Pierre-Kahn A; Brauner R
    Eur J Pediatr; 2000 May; 159(5):348-55. PubMed ID: 10834520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Premature thelarche: identification of clinical and laboratory data for the diagnosis of precocious puberty.
    Della Manna T; Setian N; Damiani D; Kuperman H; Dichtchekenian V
    Rev Hosp Clin Fac Med Sao Paulo; 2002; 57(2):49-54. PubMed ID: 11981584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do all girls with apparent idiopathic precocious puberty require gonadotropin-releasing hormone agonist treatment?
    Léger J; Reynaud R; Czernichow P
    J Pediatr; 2000 Dec; 137(6):819-25. PubMed ID: 11113839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Puberty and growth in children and adolescents with neuro fibromatosis type 1].
    Viana AC; Liberatore Junior R; Goloni Bertollo EM
    Rev Assoc Med Bras (1992); 2004; 50(2):163-6. PubMed ID: 15286864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and endocrinologic study of precocious puberty in girls.
    Ortner A; Glatzl J; Karpellus E
    Arch Gynecol; 1987; 240(2):81-93. PubMed ID: 3551851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial male-limited precocious puberty in neurofibromatosis type I.
    Lim YY; Chan RM; Loke KY; Ho CW; Lee YS
    Eur J Pediatr; 2014 Feb; 173(2):219-22. PubMed ID: 23982246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Precocious puberty: clinical and endocrine profile and factors indicating neurogenic precocity in Indian children.
    Bajpai A; Sharma J; Kabra M; Kumar Gupta A; Menon PS
    J Pediatr Endocrinol Metab; 2002; 15(8):1173-81. PubMed ID: 12387516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sexual precocity in boys: accelerated versus slowly progressive puberty gonadotropin-suppressive therapy and final height.
    Lazar L; Pertzelan A; Weintrob N; Phillip M; Kauli R
    J Clin Endocrinol Metab; 2001 Sep; 86(9):4127-32. PubMed ID: 11549638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment with a gonadotropin-releasing-hormone analog and attainment of full height potential in a male monozygotic twin with gonadotropin-releasing hormone-dependent precocious puberty.
    Ishii T; Sato S; Anzo M; Sasaki G; Hasegawa T; Tamai S; Matsuo N
    Eur J Pediatr; 1999 Nov; 158(11):933-5. PubMed ID: 10541952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of true precocious puberty with a potent luteinizing hormone-releasing factor agonist: effect on growth, sexual maturation, pelvic sonography, and the hypothalamic-pituitary-gonadal axis.
    Styne DM; Harris DA; Egli CA; Conte FA; Kaplan SL; Rivier J; Vale W; Grumbach MM
    J Clin Endocrinol Metab; 1985 Jul; 61(1):142-51. PubMed ID: 3923027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adult height after cranial irradiation for optic pathway tumors: relationship with neurofibromatosis.
    Huguenin M; Trivin C; Zerah M; Doz F; Brugieres L; Brauner R
    J Pediatr; 2003 Jun; 142(6):699-703. PubMed ID: 12838200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of gonadotropin-releasing analog treatment for children with central precocious puberty: 15-year experience in southern Thailand.
    Jaruratanasirikul S; Thaiwong M
    J Pediatr Endocrinol Metab; 2011; 24(7-8):519-23. PubMed ID: 21932591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presentation and evolution of organic central precocious puberty according to the type of CNS lesion.
    Trivin C; Couto-Silva AC; Sainte-Rose C; Chemaitilly W; Kalifa C; Doz F; Zerah M; Brauner R
    Clin Endocrinol (Oxf); 2006 Aug; 65(2):239-45. PubMed ID: 16886967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Precocious puberty in children with neurofibromatosis type 1.
    Habiby R; Silverman B; Listernick R; Charrow J
    J Pediatr; 1995 Mar; 126(3):364-7. PubMed ID: 7869193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Precocious puberty and statural growth.
    Carel JC; Lahlou N; Roger M; Chaussain JL
    Hum Reprod Update; 2004; 10(2):135-47. PubMed ID: 15073143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum sex hormone-binding globulin levels in healthy children and girls with precocious puberty before and during gonadotropin-releasing hormone agonist treatment.
    Sørensen K; Andersson AM; Skakkebaek NE; Juul A
    J Clin Endocrinol Metab; 2007 Aug; 92(8):3189-96. PubMed ID: 17519314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.